Subsequently, we analyzed the distribution of Th1 cell-related cytokines in the peripheral blood of participants, and found that the CXCR6 ligand CXCL16 was slightly upregulated in the peripheral blood of stage IV colorectal cancer patients; however, no significant differences were observed (Figure 5C). This evidence concerns the gene CXCL16 and colorectal cancer.